Soffer Gad 4
4 · Atara Biotherapeutics, Inc. · Filed Feb 8, 2018
Insider Transaction Report
Form 4
Soffer Gad
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2018-02-06$35.80/sh−3,987$142,735→ 269,749 total - Award
Common Stock
2018-02-06+17,500→ 273,736 total - Award
Employee Stock Option (Right to Buy)
2018-02-06+35,000→ 35,000 totalExercise: $35.80Exp: 2025-02-06→ Common Stock (35,000 underlying)
Footnotes (3)
- [F1]These restricted stock units vest in four equal annual installments on each of the first, second, third and fourth anniversaries of the grant date, subject to the reporting person's continuous service.
- [F2]Shares withheld to cover tax obligation from settlement of vested restricted stock units.
- [F3]1/48th of the shares subject to the stock option vest and become exercisable each month following February 6, 2018.